Patent · US Active

Transdermal carrier

US12070503B2 · kind B2 · utility

0Cited by
39References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 21, 2022
Grant dateAug 27, 2024
Priority date
Expiry dateSep 21, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61Q19/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Improved formulations for topical treatment that ensure at least localized transdermal or systemic delivery of an active agent through skin, nails or hair follicles are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.